RhumbLine Advisers’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135
| Closed | -$301 | – | 4138 |
|
|
2025
Q1 | $301 | Hold |
135
| – | – | ﹤0.01% | 4074 |
|
|
2024
Q4 | $395 | Hold |
135
| – | – | ﹤0.01% | 4108 |
|
|
2024
Q3 | $351 | Hold |
135
| – | – | ﹤0.01% | 4133 |
|
|
2024
Q2 | $399 | Hold |
135
| – | – | ﹤0.01% | 4296 |
|
|
2024
Q1 | $611 | Buy |
+135
| New | +$611 | ﹤0.01% | 4179 |
|
|
2023
Q3 | – | Sell |
-9,393
| Closed | -$60.7K | – | 4309 |
|
|
2023
Q2 | $60.7K | Sell |
9,393
-291,062
| -97% | -$1.88M | ﹤0.01% | 3641 |
|
|
2023
Q1 | $2.27M | Buy |
300,455
+6,398
| +2% | +$48.2K | ﹤0.01% | 1736 |
|
|
2022
Q4 | $2.98M | Buy |
294,057
+6,545
| +2% | +$66.3K | ﹤0.01% | 1578 |
|
|
2022
Q3 | $2.84M | Buy |
287,512
+21,959
| +8% | +$217K | ﹤0.01% | 1573 |
|
|
2022
Q2 | $2.83M | Buy |
+265,553
| New | +$2.83M | ﹤0.01% | 1568 |
|